SYMBOL:

    Up to 100 tickers separated by a space .....Watch Post-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
ATHERONOVA INC
(NQPK:AHRO Last Sale: .59 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQPK: (AHRO : $.59)
$21 million Market Cap at September 12, 2013
Biomedics SubIndustry up .00% / Health Industry up .00% Today
Irvine, CA Research Report Earnings Snapshot - Last 11/19/18
Fact Sheet
Financial Statements
Peer Comparison
Annual Reports


AtheroNova is an early stage biotech company focused on the discovery, research, development and licensing of novel compounds designed to reduce or eliminate atherosclerotic plaque deposits. AtheroNova has developed intellectual property for a class of compounds that have the potential to significantly reduce the incidence and severity of atherosclerosis.
Historical Charts    Technical Analysis
No Historical Data available for AHRO

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common AHRO $.59 $ 0 $.56 $.61 65,672 $.35 $.89 36,265
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $21,396

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex